Cargando…
Cysteamine Suppresses Invasion, Metastasis and Prolongs Survival by Inhibiting Matrix Metalloproteinases in a Mouse Model of Human Pancreatic Cancer
BACKGROUND: Cysteamine, an anti-oxidant aminothiol, is the treatment of choice for nephropathic cystinosis, a rare lysosomal storage disease. Cysteamine is a chemo-sensitization and radioprotection agent and its antitumor effects have been investigated in various tumor cell lines and chemical induce...
Autores principales: | Fujisawa, Toshio, Rubin, Benjamin, Suzuki, Akiko, Patel, Prabhudas S., Gahl, William A., Joshi, Bharat H., Puri, Raj K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332081/ https://www.ncbi.nlm.nih.gov/pubmed/22532830 http://dx.doi.org/10.1371/journal.pone.0034437 |
Ejemplares similares
-
Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
por: Fujisawa, Toshio, et al.
Publicado: (2011) -
Analysis of interleukin-13 receptor alpha2 expression as a prognostic biomarker in surgically resected pancreatic cancer patients
por: Fujisawa, Toshio, et al.
Publicado: (2015) -
Interleukin 13 receptor alpha 2 directed immunotherapy targets hepatic fibrosis and tumorigenesis induced by choline deficient diet in an in vivo mouse model of nonalcoholic steatohepatitis
por: Fujisawa, Toshio, et al.
Publicado: (2014) -
Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
por: Fujisawa, Toshio, et al.
Publicado: (2013) -
IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer
por: Fujisawa, Toshio, et al.
Publicado: (2021)